Akoua-Koffi C G, Nekouressi G, Tieoulou L, Guillot S, Faye-Kette H, Ehouman A
Laboratoire des entérovirus, Institut Pasteur de Côte d'Ivoire, BP 490 Abidjan 01, Côte d'Ivoire.
Bull Soc Pathol Exot. 2004 May;97(2):87-90.
Wild Poliovirus spreading in rural environment in Adzopé, Côte d'Ivoire In order to determine the level of wild Poliovirus spreading among rural children in an endemic poliomyelitis country 469 stools samples, from children aged between three weeks and twelve years old were processed according to WHO procedures for transportation, conservation, isolation and identification of Poliovirus. Intratypic differenciation was performed by an antigenic method using monoclonal antibodies and a genomic RFLP (Restriction Fragment Length Polymorphism). 50 Poliovirus strains (10.7%) were isolated and analyzed: 15 vaccine-like Poliovirus type 1 (30%), 30 vaccine-like Poliovirus type 2 (60%), 4 vaccine-like Poliovirus type 3 (8%) and one wild Poliovirus type 3 (2%). As expected, in the major cases the duration of post-vaccinal viral excretion did not exceed two months. However, in 14% of cases, it varied between 3 and 9 months after the third OPV dose. This long excretion could be due to an inefficient local intestinal immunity or no local immunity at all, in spite of the three OPV doses. These results argue in favor of an increase of the number of OPV doses in such endemic zones. Moreover, OPV strains are well-known to revert to pathogenicity in vaccinees, therefore, the long term excretion of pathogenic OPV derived strains by a certain amount of vaccinees needs to be considered quite seriously.
野生脊髓灰质炎病毒在科特迪瓦阿佐佩农村地区传播 为确定野生脊髓灰质炎病毒在脊髓灰质炎流行国家农村儿童中的传播水平,按照世界卫生组织关于脊髓灰质炎病毒运输、保存、分离和鉴定的程序,对469份来自3周龄至12岁儿童的粪便样本进行了处理。采用单克隆抗体抗原法和基因组限制性片段长度多态性(RFLP)法进行型内鉴别。分离并分析了50株脊髓灰质炎病毒(10.7%):15株疫苗衍生脊髓灰质炎1型病毒(30%)、30株疫苗衍生脊髓灰质炎2型病毒(60%)、4株疫苗衍生脊髓灰质炎3型病毒(8%)和1株野生脊髓灰质炎3型病毒(2%)。正如预期的那样,在大多数情况下,疫苗接种后病毒排泄持续时间不超过两个月。然而,在14%的病例中,第三剂口服脊髓灰质炎疫苗(OPV)后3至9个月病毒排泄持续时间不等。尽管接种了三剂OPV,但这种长时间排泄可能是由于局部肠道免疫效率低下或根本没有局部免疫。这些结果支持在这类流行地区增加OPV接种剂量。此外,众所周知,OPV毒株在疫苗接种者体内会恢复致病性,因此,必须认真考虑一定数量的疫苗接种者长期排泄致病性OPV衍生毒株的问题。